These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4551588)

  • 41. [On testing the sensitivity of bacteria to nitrofurans. 2. Determination of 5-nitrofuraldehyde-(2)-semicarbazone concentration in the diffusion area during the scatter test].
    Weuffen W; Bĕhounková L; Kappe D
    Z Gesamte Hyg; 1968 Mar; 14(3):194-6. PubMed ID: 4896791
    [No Abstract]   [Full Text] [Related]  

  • 42. Gentamicin- and neomycin-resistant mutants of Escherichia coli K-12 cross-resistant to nitrofurans.
    Obaseiki-Ebor EE; Breeze AS
    J Antimicrob Chemother; 1984 Jun; 13(6):567-76. PubMed ID: 6147338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nitrofuran mutagenicity: induction of frameshift mutations.
    Obaseiki-Ebor EE; Akerele JO
    Mutat Res; 1986 Nov; 175(3):149-52. PubMed ID: 3534559
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparative evaluation of the antibacterial activity of nitrofuran derivatives].
    Szozda G; Nowakowska K; Pawluch D
    Pol Tyg Lek; 1987 Aug 3-10; 42(31-32):967-9. PubMed ID: 3120163
    [No Abstract]   [Full Text] [Related]  

  • 45. Differential effects of nitrofurans on the production/release of steroid hormones by porcine adrenocortical cells in vitro.
    Jager LP; de Graaf GJ; Widjaja-Greefkes HC
    Eur J Pharmacol; 1997 Jul; 331(2-3):325-31. PubMed ID: 9274996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An update on the role of nitrofurans in the management of urinary tract infections.
    Guay DR
    Drugs; 2001; 61(3):353-64. PubMed ID: 11293646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell division and prophage induction in Escherichia coli: effects of pantoyl lactone and various furan derivatives.
    Kirby EP; Ruff WL; Goldthwait DA
    J Bacteriol; 1972 Aug; 111(2):447-53. PubMed ID: 4559732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
    Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism of nitrofuran resistance in Salmonella enteritidis phage type 4 and interpretation of nitrofuran susceptibility tests.
    Brown DF; Upson R; Brenwald NP; Rampling A
    J Antimicrob Chemother; 1991 Jan; 27(1):23-8. PubMed ID: 2050594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nifuratrone, a new nitrofuran: in vitro and in vivo activities.
    Ritter HW; Hoffmann PF; Ledbetter RR; Krueger RF
    Antimicrob Agents Chemother (Bethesda); 1970; 10():254-9. PubMed ID: 4939734
    [No Abstract]   [Full Text] [Related]  

  • 51. Occurrence and transfer of antibiotic resistance, colicinogeny and haemolysin production in Escherichia coli strains isolated from cases of colibacillosis.
    Swiderski M; Lachowicz TM
    Acta Microbiol Pol A; 1974; 6(2):155-62. PubMed ID: 4600128
    [No Abstract]   [Full Text] [Related]  

  • 52. Inhibition of conjugal transfer of R plasmids by nitrofurans.
    Michel-Briand Y; Laporte JM
    J Gen Microbiol; 1985 Sep; 131(9):2281-4. PubMed ID: 3906037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Small-cell formation of Staphylococcus aureus by subinhibitory concentrations of nitrofuran derivatives.
    Koike M; Iida K; Nakashima K; Tokunaga J
    J Bacteriol; 1974 Oct; 120(1):524-6. PubMed ID: 4421698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
    Borsari AG; Bucher B; Brazzola P; Simonetti GD; Dolina M; Bianchetti MG
    Clin Ther; 2008 Nov; 30(11):2090-5. PubMed ID: 19108796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimicrobial activity of 5-nitro-2-furaldehyde-N'-methyl-N-piperazinoacethydrazone, a new hydrosoluble nitrofurane derivative. I. In vivo antibacterial activity.
    Degen L; Salvaterra M; Vella S
    Chemotherapy; 1972; 17(3):175-81. PubMed ID: 4556173
    [No Abstract]   [Full Text] [Related]  

  • 56. [Biochemical bases for the effect of combining kanamycin and nitrofuran resistance genes in Escherichia coli cells].
    Morozov GI; Nosova LIu; Biketov SF; Valiaev AG; Domaradskiĭ IV
    Mol Gen Mikrobiol Virusol; 1994; (2):11-4. PubMed ID: 8183300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Drug resistance induced by conjugated R-plasmids in E. coli isolated from swine-breeding facilities].
    Bineva I; Korudzhiĭski N; Karadzhov S
    Vet Med Nauki; 1982; 19(4):18-23. PubMed ID: 6758316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Minimum inhibitory concentration of furazolidone for E. coli and salmonella strains isolated in Nigeria.
    Ojo MO; Ahanihu LO
    Vet Rec; 1974 Mar; 94(9):172. PubMed ID: 4593537
    [No Abstract]   [Full Text] [Related]  

  • 59. Oxygen-insensitive nitroreductases: analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli.
    Whiteway J; Koziarz P; Veall J; Sandhu N; Kumar P; Hoecher B; Lambert IB
    J Bacteriol; 1998 Nov; 180(21):5529-39. PubMed ID: 9791100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced nitrofuran sensitivity conferred by R factors.
    Aoki T; Egusa S; Arai T
    Jpn J Microbiol; 1975 Aug; 19(4):327-9. PubMed ID: 1104937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.